Skip to main content

Table 1 Antifungal susceptibility of oral Candida albicans isolates from HIV-infected patients

From: Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis

Antifungal agents

Drug concentration

Resistance (%)

Intermediate (%)

Susceptible (%)

Fluconazole (FCN)

25 μg

32

10

58

Clotrimazole (CTM)

10 μg

14

16

70

Nystatin (NY)

100 units

0

0

100

Amphotericin B (AMB)

20 μg

0

4

96

Ketoconazole (KCA)

10 μg

28

10

62

Flucytosine (FY)

1 μg

100

0

0